Seeking Alpha

CMRX
  Chimerix Inc - NASDAQ

8/20/2014, 1:14 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
CMRX vs. ETF Alternatives
Company Description
Chimerix Inc is a biopharmaceutical company that develops and commercializes oral antivirals. It has two compounds in clinical development: CMX001 and CMX157.